Eisai
4523.T
#1963
Rank
NZ$14.27 B
Marketcap
$50.65
Share price
1.30%
Change (1 day)
-27.96%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): NZ$0.72 Billion

According to Eisai's latest financial reports the company's current earnings are NZ$5.06 Billion. In 2023 the company made an earning of NZ$0.91 Billion, an increase over its 2022 earnings that were of -NZ$39.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.72 B-21.11%
2023 NZ$0.91 B-2392.87%
2022 -NZ$39.91 Million-103.6%
2021 NZ$1.10 B-39.52%
2020 NZ$1.83 B7.3%
2019 NZ$1.70 B17.23%
2018 NZ$1.45 B86.06%
2017 NZ$0.78 B-23.64%
2016 NZ$1.02 B27.28%
2015 NZ$0.80 B22.08%
2014 NZ$0.66 B-46.11%
2013 NZ$1.22 B-21.67%
2012 NZ$1.56 B-20.72%
2011 NZ$1.97 B-8.44%
2010 NZ$2.15 B18.85%
2009 NZ$1.81 B